Literature DB >> 23816886

MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death.

Waihay J Wong1, Bo Qiu, Michael S Nakazawa, Guoliang Qing, M Celeste Simon.   

Abstract

Cells encounter oxygen deprivation (hypoxia) in various physiological and pathological contexts. Adaptation to hypoxic stress occurs in part by suppressing MYC, a key regulator of cellular metabolism, proliferation, and survival. Hypoxia has been reported to inhibit MYC through multiple means, including disruption of MYC transcriptional complexes and decreased MYC protein abundance. Here we identify enhanced proteasomal degradation and cathepsin-mediated proteolysis as important mechanisms for hypoxic MYC inhibition in human colon carcinoma cells. MYC protein levels were similarly reduced in hypoxic primary keratinocytes. Increased MYC turnover at low O2 tension was dependent on the E3 ubiquitin ligases FBXW7 and DDB1, as well as hypoxic induction of cathepsins D and S. Reduced MYC protein levels coincided with hypoxic inhibition of RNA polymerase III-dependent MYC target genes, which MYC regulates independently of its binding partner MAX. Finally, MYC overexpression in hypoxic cells promoted cell cycle progression but also enhanced cell death via increased expression of the proapoptotic genes NOXA and PUMA. Collectively, these results indicate that hypoxic cells promote MYC degradation as an adaptive strategy to reduce proliferation, suppress biosynthetic processes, and promote cell survival under low O2 tension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23816886      PMCID: PMC3753854          DOI: 10.1128/MCB.00853-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

2.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

3.  Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.

Authors:  Nikita Popov; Christina Schülein; Laura A Jaenicke; Martin Eilers
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

4.  Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Authors:  David N Boone; Ying Qi; Zhaoliang Li; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

5.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

6.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

7.  Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

Authors:  Meaghan Wall; Gretchen Poortinga; Katherine M Hannan; Richard B Pearson; Ross D Hannan; Grant A McArthur
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

8.  HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.

Authors:  John D Gordan; Priti Lal; Vijay R Dondeti; Richard Letrero; Krishna N Parekh; C Elisa Oquendo; Roger A Greenberg; Keith T Flaherty; W Kimryn Rathmell; Brian Keith; M Celeste Simon; Katherine L Nathanson
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743

Review 9.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

10.  BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha.

Authors:  Jee-Youn Kim; Hyun-Jong Ahn; Jong-Hoon Ryu; Kyoungho Suk; Jae-Hoon Park
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

View more
  21 in total

1.  Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Authors:  Dashnamoorthy Ravi; Afshin Beheshti; Nasséra Abermil; Frank Passero; Jaya Sharma; Michael Coyle; Athena Kritharis; Irawati Kandela; Lynn Hlatky; Michail V Sitkovsky; Andrew Mazar; Ronald B Gartenhaus; Andrew M Evens
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

Review 2.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

3.  Nickel-induced HIF-1α promotes growth arrest and senescence in normal human cells but lacks toxic effects in transformed cells.

Authors:  Michal W Luczak; Anatoly Zhitkovich
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-25       Impact factor: 4.219

4.  Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.

Authors:  Chunxia Zhou; Lincai Ye; Chuan Jiang; Jie Bai; Yongbin Chi; Haibo Zhang
Journal:  Tumour Biol       Date:  2015-06-19

Review 5.  Regulation of cell proliferation by hypoxia-inducible factors.

Authors:  Maimon E Hubbi; Gregg L Semenza
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-21       Impact factor: 4.249

6.  Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.

Authors:  Hoda Soleymani Abyaneh; Nidhi Gupta; Abdulraheem Alshareef; Keshav Gopal; Afsaneh Lavasanifar; Raymond Lai
Journal:  Cancer Microenviron       Date:  2018-09-25

7.  Differential responses of blood-brain barrier associated cells to hypoxia and ischemia: a comparative study.

Authors:  Sabrina Engelhardt; Sheng-Fu Huang; Shalmali Patkar; Max Gassmann; Omolara O Ogunshola
Journal:  Fluids Barriers CNS       Date:  2015-02-17

8.  MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer.

Authors:  Chuanqing Jing; Rong Fu; Can Wang; Xiurong Li; Wei Zhang
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989

9.  ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate.

Authors:  Melissa M Keenan; Beiyu Liu; Xiaohu Tang; Jianli Wu; Derek Cyr; Robert D Stevens; Olga Ilkayeva; Zhiqing Huang; Laura A Tollini; Susan K Murphy; Joseph Lucas; Deborah M Muoio; So Young Kim; Jen-Tsan Chi
Journal:  PLoS Genet       Date:  2015-10-09       Impact factor: 5.917

10.  Stress-induced cleavage of Myc promotes cancer cell survival.

Authors:  Maralice Conacci-Sorrell; Celine Ngouenet; Sarah Anderson; Thomas Brabletz; Robert N Eisenman
Journal:  Genes Dev       Date:  2014-04-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.